Editorial Board
Costica Aloman
Rush University Medical Center · United States
Editorial leadership for Journal of Tissue Repair and Regeneration ISSN 2640-6403
Research interests
- Dendritic Cell Biology (Development
- Function) Liver Fibrosis Biology (Immune Modulation) Autoimmunity Immune Tolerance
- Rejection After Solid Organ Transplants Il15 Signaling
Biography
- Dr. Costica Aloman, MD is a gastroenterology specialist in Chicago, IL and has been practicing for 23 years.
- He graduated from Universitatea De Medicina Si Farmacie Carol Davila, Facultatea De Medicina in 1995 and specializes in gastroenterology and transplant hepatology.
- Dr. Costica Aloman is currently the Medical Director of the Liver Transplant Program at Rush University Medical Center.
- He has over 8 years of experience in transplant hepatology, gastroenterology, and internal medicine.
- His expertise includes alcoholic liver disease, autoimmune disorders, autoimmune hepatitis, liver cirrhosis, liver cancer, adult liver transplant and living donor liver transplantation.
- Dr. Aloman's research is focused on understanding alcohol effects on immune system, developing antifibrotic agents, deciphering dendritic cell development and fibrosis biology.
- Dr. Aloman is currently a member of the American Association for the Study of Liver Diseases (AASLD) and the American College of Physicians.
- His awards include the AASLD-ALF Liver Scholar Award (2011) and AASLD Advance Hepatology Fellowship Grant (2007).
- Dr. Aloman currently has an academic appointment from the Department of Medicine, Division of Gastroenterology and Hepatology, Section of Hepatology, Rush Medical College.
- He is a Hepatology Teaching Attending in the Gastroenterology and Hepatology Fellowship Program at Rush University Medical Center.
Selected publications
- Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma 2022 cited 17×
- Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity Recent 2025 cited 3×
- Recipient risk factors for acute cellular rejection after orthotopic liver transplant ‐ a single‐center, retrospective study 2020 cited 3×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JTRR for your work?
This journal is guided by Costica Aloman (Rush University Medical Center) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.